Cannabis Industry B2B Directory: Featured Businesses
Back You are here: Home News Company News Medical Marijuana Inc.'s HempMedsPX Leading the Industry With Hemp-Based Cannabidiol (CBD) Products

Medical Marijuana Inc.'s HempMedsPX Leading the Industry With Hemp-Based Cannabidiol (CBD) Products

Real Scientific Hemp Oil (RSHO)SAN DIEGO, Calif.— Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX—a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc.— entered the "High CBD (cannabidiol) Award"-winning product at the High Times Medical Cannabis Cup in Seattle, Washington. Submitted by HempMedsPX on behalf of PhytoSPHERE Systems, the prototype product CBD Simple tested at a record 95.8% CBD, the highest CBD percentage ever documented at the Cannabis Cup.

All entries were tested by Analytical 360 and Northwest Botanical Analysis, the independent laboratories employed by the High Times Medical Cannabis Cup for this competition, and were further assessed by an expert panel for additional attributes such as taste, smell, and visual presentation. CBD Simple returned a CBD percentage of 95.8%, resulting in a sweep of the High CBD—Concentrates category. HempMedsPX received the confirmed test results earlier this week.

"The enthusiasm for high-CBD products at the Cup represents a huge shift in cannabis culture," said Chris Boucher, Vice President of Product Development for HempMedsPX. "This was the first time the company entered any products into a competition of this kind, and we are thrilled with the result. The support for what we are doing from the cannabis community was overwhelming."

Michael Mona Jr., President and CEO of CannaVest Corp., accepted the award in Seattle on behalf ofPhytoSPHERE Systems and HempMedsPX. "We are very thankful for the hard work of our friends at HempMedsPX, and for the incredible PhytoSPHERE team that produced this game-changing product. We are excited to work together to bring standardized, hemp-based high CBD products to the market," said Mona Jr.

The two-day event was held in Seattle, Washington on September 7-8, 2013. To see the full results of the competition, please visit

For more information or to purchase hemp CBD products, please visit or call 866-273-8502.

About HempMedsPX

HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution of hemp cannabidiol (CBD) products, HempMedsPX is the communication hub for the Medical Marijuana Inc. family of companies.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at:

About CannaVest Corp.

CannaVest Corp. (OTC:CANV) is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company's supply relationships in Europe. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and CBD is derived from hemp stalk and seed. Additional information is available from or by visiting

About PhytoSPHERE Systems

PhytoSPHERE Systems is a global phytocannabinoid biotechnology company based in San Diego, California with an exclusive license for use by CannaVest Corp. (OTC:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products.

PhytoSPHERE Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to "strains") that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit:


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from the statements made herein.


Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana based products within certain international markets.

SOURCE: Medical Marijuana Inc.